Sunovion Pharmaceuticals Canada Inc., a subsidiary of Sunovion Pharmaceuticals, Inc., is a prominent player in the Canadian pharmaceutical industry, headquartered in CA. Founded in 2010, the company has established itself as a leader in developing innovative treatments for central nervous system disorders, including schizophrenia and depression. With a strong focus on research and development, Sunovion is dedicated to delivering unique therapeutic solutions that enhance patient outcomes. Their core products, such as Lurasidone and Brexpiprazole, are distinguished by their efficacy and safety profiles, setting them apart in a competitive market. Sunovion's commitment to advancing mental health care has earned it recognition within the industry, positioning the company as a trusted partner in improving the lives of patients across Canada.
We don't have data for Sunovion Pharmaceuticals Canada Inc., but we can show you information about their parent organization instead.
View parent company